Direxion Torqueable Microcatheter, NGMC/SINGLE/027/BERN/1RO/105; Material Number: M001195430 Recall
Direxion Torqueable Microcatheter, NGMC/SINGLE/027/BERN/1RO/105; Material Number: M001195430
FDA recall Class II
Ongoing
FDA lists this Class II recall for Direxion Torqueable Microcatheter, NGMC/SINGLE/027/BERN/1RO/105; Material Number: M001195430. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-0242-2027
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Sep 16, 2026
- FDA report date
- Oct 28, 2026
- Quantity in commerce
- 76
- Distribution
- See key details
- FDA cause
- Process control
What is being recalled?
Direxion Torqueable Microcatheter, NGMC/SINGLE/027/BERN/1RO/105; Material Number: M001195430
The retrieved code information does not contain explicit model/GTIN pairs that this publication can reliably map.
Search FDA identifier text
Search a model, catalog, lot or UDI value exactly as printed in FDA’s product description or code information.
This search checks only the FDA product description and code information displayed on this page. It does not decode a UDI, normalize GTIN lengths or establish a relationship between separately listed codes.
FDA code information
Material Number: M001195430; UDI-DI: 08714729839507; Batch Numbers: 38149822, 38210076, 38415917, 38595649, 38708406, 39141265;
Why was this product recalled?
The product is defective due to insufficient UV curing of the hydrophilic coating which is present on the outer surface of the distal segment of the microcatheters and raised ridges on nitinol sleeves due to laser cutting misalignment.
What actions did Boston Scientific Cork, Ltd. take?
On September 16, 2026, Urgent Medical Device Removal - Immediate Action Required letters were sent to customers. Actions to be taken: 1. Immediately stop further use or distribution and segregate affected product (see Attachment 1 for identification of the affected devices). 2. Forward this notice to relevant personnel and any facilities to which the product was transferred. 3. Continue to follow the standard of practice when monitoring patients treated with the product. 4. Complete and return the enclosed Reply Verification Tracking Form per the included instructions. 5. Return product to Boston Scientific in accordance with the enclosed instructions.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-0242-2027
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 19, 2026
- openFDA device recall record · Source release Nov 14, 2026 · Retrieved Nov 19, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology